Contact details
Dr Petra Wark
Research Fellow
School of Public Health
502
Norfolk Place
St Mary's Campus
Tel: +44 (0)20 7594 8477
Email:
Dr Petra Wark
M.Sc. Ph.D.
Petra has a MSc in Biomedical Health Sciences from the University of Nijmegen (now: Radboud University; major: epidemiology, minors: oncology, nutrition, psychology; 2000) and a PhD from Wageningen University, the Netherlands. Her thesis examined the relationships of dietary, lifestyle, and heritable risk factors with histopathological and molecular characteristics of colorectal polyps and cancer. Whilst working on her PhD, she completed several courses in Applied Statistics and Biostatistics at Hasselt University, Belgium (2000-2003), and she was as guest researcher at the Department of Nutrition of Harvard School of Public Health, Boston, US for nine months (2003). From 2005 to 2008 she worked at the London School of Hygiene and Tropical Medicine (LSHTM) in the Cancer Research UK Epidemiology and Genetics Group; she was, amongst others, involved in studies on the long-term health effects of the use of ovulation-stimulation drugs and immunosuppression as well as in a methodological project embedded in the European Prospective Investigation into Cancer and Nutrition (EPIC) study (in collaboration with Imperial College). Petra's interest in teaching and education became clear when she was doing LSHTM's Introductory Certificate in Learning and Teaching (2007-2008).
She has been working at Imperial College since 2009. She organises the International Course in Nutritional Epidemiology, the first edition of which took place in 2009. She also contributes to several teaching units on epidemiology at undergraduate and postgraduate level. This - in combination with her research that concentrates on the nutritional and lifestyle determinants of cancer and longevity in the EPIC study - perfectly matches Petra's ambitions.
Selected Publications
Journals
- Wark PA; Wu K; van 't Veer P; Fuchs CF; Giovannucci EL. (15 Jul 2009). Family history of colorectal cancer: a determinant of advanced adenoma stage or adenoma multiplicity?. Int J Cancer. 125:413-420. DOI.
- Silva ID; Wark PA; McCormack VA; Mayer D; Overton C; Little V; Nieto J; Hardiman P; et alDavies M; MacLean AB. (26 May 2009). Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. BRIT J CANCER. 100:1824-1831. DOI.
- Wark PA; Van der Kuil W; Ploemacher J; Van Muijen GN; Mulder CJ; Weijenberg MP; Kok FJ; Kampman E. (15 Jul 2006). Diet, lifestyle and risk of K-ras mutation-positive and -negative colorectal adenomas. Int J Cancer. 119:398-405. DOI.
- Wark PA; Weijenberg MP; van 't Veer P; van Wijhe G; Lüchtenborg M; van Muijen GN; de Goeij AF; Goldbohm RA; et alvan den Brandt PA. (Jul 2005). Fruits, vegetables, and hMLH1 protein-deficient and -proficient colon cancer: The Netherlands cohort study. Cancer Epidemiol Biomarkers Prev. 14:1619-1625. DOI.
- Wark PA; Grubben MJ; Peters WH; Nagengast FM; Kampman E; Kok FJ; van 't Veer P. (Nov 2004). Habitual consumption of fruits and vegetables: associations with human rectal glutathione S-transferase. Carcinogenesis. 25:2135-2142. DOI.
- Tiemersma EW; Wark PA; Ocké MC; Bunschoten A; Otten MH; Kok FJ; Kampman E. (May 2003). Alcohol consumption, alcohol dehydrogenase 3 polymorphism, and colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 12:419-425.
Chapters in books
- Wark PA; Peto J. Cancer Epidemiology. In International Encyclopedia of Public Health. 1:416-424. Heggenhougen K (ed); Quah S (ed). Academic Press, San Diego (2008). Publisher weblink.


